Anatara Lifesciences Ltd has released a press release.
Appendix 4C and Q2 FY22 Activities Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Anatara Lifesciences Ltd on 6ix
Story so far
Earlier from Anatara Lifesciences
- Change of Director's Interest Notice
- Notification regarding unquoted securities - ANR
- Application for quotation of securities - ANR
- AGM CEO Presentation
- Chairmans Address to Shareholders
Later from Anatara Lifesciences
- Half Year Accounts
- Clinical Trials Update
- Appendix 4C and Q3 FY22 Activities Report
- Anatara Lifesciences announces leadership change
- Clinical Trial and Operational Update
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences